The Serine/Threonine Kinase PAK4 Prevents Caspase Activation and Protects Cells from Apoptosis

187Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The serine/threonine kinase PAK4 was identified first as an effector molecule for the Rho GTPase Cdc42. PAK4 differs from other members of the PAK family both in sequence and function. Previously we have shown that an important function of this kinase is to mediate the induction of filopodia in response to activated Cdc42. Studies with a constitutively active PAK4 mutant have shown that it also has a role in promoting anchorage-independent growth, an important hallmark of oncogenic transformation. Here we show that another function of PAK4 is to protect cells against apoptotic cell death. Expression of wild-type or constitutively active PAK4 delays the onset of apoptosis in response to tumor necrosis factor α stimulation, UV irradiation, and serum starvation. Consistent with an antiapoptotic function, expression of PAK4 leads to an increase in phosphorylation of the proapoptotic protein Bad and an inhibition of caspase activation.

Cite

CITATION STYLE

APA

Gnesutta, N., Qu, J., & Minden, A. (2001). The Serine/Threonine Kinase PAK4 Prevents Caspase Activation and Protects Cells from Apoptosis. Journal of Biological Chemistry, 276(17), 14414–14419. https://doi.org/10.1074/jbc.m011046200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free